| Secondary |
| Drug Use For Unknown Indication |
15.4% |
| Prophylaxis |
11.8% |
| Rheumatoid Arthritis |
10.2% |
| Hiv Infection |
8.3% |
| Pneumonia |
7.5% |
| Adult T-cell Lymphoma/leukaemia |
5.5% |
| Hypertension |
5.4% |
| Antifungal Prophylaxis |
4.8% |
| Renal Transplant |
4.5% |
| Product Used For Unknown Indication |
4.1% |
| Infection Prophylaxis |
3.2% |
| Interstitial Lung Disease |
3.0% |
| Pneumocystis Jiroveci Pneumonia |
2.5% |
| Pneumocystis Jirovecii Pneumonia |
2.5% |
| Acquired Immunodeficiency Syndrome |
2.3% |
| Pyrexia |
2.1% |
| Hodgkin's Disease |
1.9% |
| Systemic Lupus Erythematosus |
1.7% |
| Insomnia |
1.7% |
| Constipation |
1.6% |
|
| White Blood Cell Count Decreased |
17.7% |
| Toxic Epidermal Necrolysis |
10.5% |
| Agranulocytosis |
6.8% |
| Renal Disorder |
6.4% |
| Rash |
5.9% |
| Renal Impairment |
5.9% |
| Pneumocystis Jiroveci Pneumonia |
5.5% |
| Pneumonia |
5.0% |
| Vomiting |
4.5% |
| Drug Eruption |
4.1% |
| Platelet Count Decreased |
4.1% |
| Pyrexia |
3.6% |
| Neutropenia |
3.2% |
| Liver Disorder |
2.7% |
| Liver Function Test Abnormal |
2.7% |
| Blood Alkaline Phosphatase Increased |
2.3% |
| Interstitial Lung Disease |
2.3% |
| Pancytopenia |
2.3% |
| Sepsis |
2.3% |
| Thrombocytopenia |
2.3% |
|
| Concomitant |
| Prophylaxis |
31.3% |
| Product Used For Unknown Indication |
9.9% |
| Drug Use For Unknown Indication |
7.3% |
| Infection Prophylaxis |
6.8% |
| Multiple Myeloma |
6.3% |
| Rheumatoid Arthritis |
5.4% |
| Hiv Infection |
5.1% |
| Hypertension |
3.6% |
| Constipation |
2.6% |
| Antifungal Prophylaxis |
2.5% |
| Neoplasm Malignant |
2.5% |
| Aplastic Anaemia |
2.3% |
| Acute Lymphocytic Leukaemia |
2.1% |
| Stem Cell Transplant |
2.1% |
| Acquired Immunodeficiency Syndrome |
1.9% |
| Insomnia |
1.8% |
| Myelodysplastic Syndrome |
1.8% |
| Immunosuppression |
1.6% |
| Diabetes Mellitus |
1.6% |
| Plasma Cell Myeloma |
1.5% |
|
| White Blood Cell Count Decreased |
22.8% |
| Sepsis |
9.5% |
| Pneumonia |
8.3% |
| Pyrexia |
6.0% |
| Vomiting |
5.8% |
| Renal Impairment |
5.2% |
| Thrombocytopenia |
4.5% |
| White Blood Cell Count Increased |
4.1% |
| Hepatic Function Abnormal |
3.9% |
| Interstitial Lung Disease |
3.9% |
| Liver Disorder |
3.8% |
| Platelet Count Decreased |
3.5% |
| Rash |
3.4% |
| Stomatitis |
3.1% |
| Respiratory Failure |
2.8% |
| Neutrophil Count Decreased |
2.0% |
| Pancytopenia |
2.0% |
| Renal Failure |
1.9% |
| Weight Increased |
1.9% |
| Gastric Cancer |
1.7% |
|
| Interacting |
| Dermatomyositis |
33.3% |
| Antifungal Prophylaxis |
16.7% |
| Cytomegalovirus Infection |
16.7% |
| Fungal Infection |
16.7% |
| Pneumocystis Jirovecii Pneumonia |
16.7% |
|
| Respiratory Failure |
100.0% |
|
